Overview

Mometasone and Markers of Airway Inflammation

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
A post-marketing study to look at the effects of Asmanex on markers of airway inflammation.
Phase:
Phase 4
Details
Lead Sponsor:
Creighton University
Collaborator:
Schering-Plough
Treatments:
Mometasone Furoate